COCP: Presentation Highlights CDI-988
By David Bautz, PhDNASDAQ: COCPREAD THE FULL COCP RESEARCH REPORTBusiness UpdatePresentation at ICAR 2026 Showcases CDI-988On April 30, 2026, Cocrystal…
0,940€
-2,08%
Echtzeit-Aktienkurs COCRYSTAL PHARMA NEW O.N.
Bid:
Ask:
Nachrichten zur COCRYSTAL PHARMA NEW O.N. Aktie
COCP: Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Prevention
By David Bautz, PhDNASDAQ: COCPREAD THE FULL COCP RESEARCH REPORTBusiness UpdateFast Track Designation for CDI-988On April 2, 2026, Cocrystal Pharma,…
Cocrystal Pharma stock surges on FDA Fast Track designation
Cocrystal Pharma stock surges on FDA Fast Track designation…
COCP: CDI-988 Data to be Presented at ICAR 2026
By David Bautz, PhDNASDAQ:COCPREAD THE FULL COCP RESEARCH REPORTBusiness UpdateCDI-988 to be Featured at ICAR2026On February 19, 2026, Cocrystal Pharma,…
Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza A
Feedback provides greater clarity on regulatory requirements for planned Phase 2b trial…